Synthesis and biological evaluation of (3'-amino-[1,1'-biphenyl]-4-yl) sulfamic acid derivatives as novel HPTPβ inhibitors

Bioorg Chem. 2018 Dec:81:270-277. doi: 10.1016/j.bioorg.2018.06.014. Epub 2018 Jun 6.

Abstract

A series of novel (3'-amino-[1,1'-biphenyl]-4-yl) sulfamic acid derivatives were designed as nonphosphonate-based phosphotyrosy (pTyr) mimetics, synthesized and screened for use as HPTPβ inhibitors. Compounds C22 and C2 showed favorable HPTPβ inhibitory activity and better selectivity for HPTPβ than for PTP1B and SHP2. Docking results suggested that compounds C2 and C22 could not only efficiently fit into the catalytic site of the HPTPβ enzyme but also interact with the Lys1807, Arg1809 and Lys1811 residues of the secondary binding site, which was next to the catalytic center of the enzyme. The mode of interaction of the synthesized compound with the protein was different from the one found in a complex crystal of small molecules with HPTPβ (2I4H), in which the inhibitory molecule formed hydrogen bonds with the Gln1948 and Asn1735 residues of the secondary binding site.

Keywords: Activity evaluation; Drug design; HPTPβ; Inhibitor; Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biphenyl Compounds / chemical synthesis
  • Biphenyl Compounds / chemistry*
  • Catalytic Domain
  • Drug Design
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 / antagonists & inhibitors*
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 / chemistry
  • Structure-Activity Relationship
  • Sulfonic Acids / chemical synthesis
  • Sulfonic Acids / chemistry*

Substances

  • Biphenyl Compounds
  • Sulfonic Acids
  • PTPRB protein, human
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3